Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Research
Biotech
Clinical Data
Venture Capital
Deals
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Cell & Gene Therapy
COVID-19
Emerging Biopharma
Podcasts
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
What are you searching for?
Enclose phrases in quotes. Use a + to require a term in results and - to exclude terms.
Example: +water -Europe
Subscribe
Research
Biotech
Clinical Data
Venture Capital
Deals
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Cell & Gene Therapy
COVID-19
Emerging Biopharma
Podcasts
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Biotech
Biotech
Sanofi CEO plots path ‘back to the magic’ in oncology
CEO Paul Hudson admitted that after some struggles with its headline candidates, the French pharma might seek solace earlier in its pipeline.
James Waldron
Feb 3, 2023 11:12am
Fierce Biotech Layoff Tracker 2023: Eisai, Vyant and more
Feb 3, 2023 11:00am
New federal biotech commission taps 12 members—Chutes & Ladders
Feb 3, 2023 10:20am
Drug discovery biotech Vyant preps to wind down operations
Feb 3, 2023 10:14am
After 18-month hold, MaaT sees end to impasse with FDA
Feb 3, 2023 9:55am
Sanofi pulls phase 3 trial of $3.7B drug as competition heats up
Feb 3, 2023 6:50am
